Trase lands $107M seed to build AI for healthcare

Trase closed a $107 million seed round led by Arch Venture Partners, with participation from Red Cell Partners and others. The company is building an AI agent infrastructure and operating system aimed at highly regulated sectors, including healthcare and defense. The raise is notable because it is unusually large for a seed round and comes before any Series A has been announced.

The startup says its platform, Trase Origin, is designed to automate repetitive administrative work while meeting compliance requirements in environments where security and privacy matter. Reported customers include Duke Health and the U.S. Navy, suggesting the product is already being used in mission-critical settings. Technical.ly reported that the company plans to use the new capital to grow its go-to-market team and continue product development.

The round underscores continued investor interest in enterprise AI infrastructure for regulated markets, where adoption tends to be slower but the operational stakes are high. Trase emerged from stealth in late 2025 with a smaller pre-seed round, and the new financing signals a much larger push to scale its commercial presence.